Kamada (KMDA) Market Capitalization (2015 - 2026)
Kamada's (KMDA) quarterly Market Capitalization came in at $423.4 million in Q2 2026, down 4.99% on a YoY basis from $445.7 million in Q2 2025, and down 11.99% quarter-over-quarter from $481.1 million in Q1 2026.
Analysis
Kamada (KMDA) Market Capitalization (2015 - 2026) Analysis & Trends
Kamada (KMDA) has reported Market Capitalization for 12 consecutive years, with $423.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization fell 4.99% year-over-year to $423.4 million; the trailing twelve-month figure through Jun 2026 stood at $423.4 million (down 4.99% YoY), and the FY2025 full-year result was $407.3 million, up 16.29% from the prior year.
- Market Capitalization retreated to $423.4 million in Q2 2026 per KMDA's latest filing, from $481.1 million in the prior quarter.
- Across five years, Market Capitalization topped out at $481.1 million in Q1 2026 and bottomed at $179.8 million in Q4 2022.
- Historically, Market Capitalization has averaged $315.0 million across 5 years, with a median of $315.6 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Market Capitalization plunged 39.01% in 2022, then soared 95.67% in 2023.
- Over 5 years, Market Capitalization stood at $179.8 million in 2022, then jumped by 95.67% to $351.8 million in 2023, then slipped by 0.45% to $350.2 million in 2024, then climbed by 16.29% to $407.3 million in 2025, then grew by 3.97% to $423.4 million in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $423.4 million, $481.1 million, and $407.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Kamada | 473.57 Mn | 403.43 Mn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 423.42 Mn |
| Mar 31, 2026 | 481.10 Mn |
| Dec 31, 2025 | 407.26 Mn |
| Sep 30, 2025 | 399.08 Mn |
| Jun 30, 2025 | 445.66 Mn |
| Mar 31, 2025 | 380.11 Mn |
| Dec 31, 2024 | 350.21 Mn |
| Sep 30, 2024 | 308.67 Mn |
| Jun 30, 2024 | 285.10 Mn |
| Mar 31, 2024 | 322.46 Mn |
| Dec 31, 2023 | 351.77 Mn |
| Sep 30, 2023 | 239.41 Mn |
| Jun 30, 2023 | 236.49 Mn |
| Mar 31, 2023 | 208.25 Mn |
| Dec 31, 2022 | 179.78 Mn |
| Sep 30, 2022 | 202.05 Mn |
| Jun 30, 2022 | 202.05 Mn |
| Mar 31, 2022 | 247.29 Mn |
| Dec 31, 2021 | 294.78 Mn |
| Sep 30, 2021 | 237.14 Mn |